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A B S T R A C T
A growing amount of evidences indicates that inflammaging – the chronic, low grade inflammation state
characteristic of the elderly – is the result of genetic as well as environmental or stochastic factors. Some of these,
such as the accumulation of senescent cells that are persistent during aging or accompany its progression, seem
to be sufficient to initiate the aging process and to fuel it. Others, like exposure to environmental compounds or
infections, are temporary and resolve within a (relatively) short time. In both cases, however, a cellular memory
of the event can be established by means of epigenetic modulation of the genome.
In this review we will specifically discuss the relationship between epigenetics and inflammaging. In parti-
cular, we will show how age-associated epigenetic modifications concerned with heterochromatin loss and gene-
specific remodelling, can promote inflammaging. Furthermore, we will recall how the exposure to specific nu-
tritional, environmental and microbial stimuli can affect the rate of inflammaging through epigenetic me-
chanisms, touching also on the recent insight given by the concept of trained immunity.
1. Introduction
Inflammaging is a major and ubiquitous characteristic of human
aging [1] conserved across a remarkable phenotypic variability [2,3].
Increased basal levels of circulating pro-inflammatory factors, such as
IL-6, TNF-α, IL-1Rα, and C-reactive protein (CRP), hallmark of in-
flammaging, have been described during aging and have been asso-
ciated with the development of a wide range of age-related pathologies
and with higher risks of mortality [4,5]. Inter-individual variations in
inflammaging and in its functional readouts rely on the intrinsic plas-
ticity of the immune system and are the result of an entangled network
of factors that operate during the life course on the genetic background
of each individual.
Some inflammaging sources [6] are intimately linked to time ero-
sion: for example, cellular divisions unavoidably occur during devel-
opment and maintenance of tissue homeostasis and lead to telomeres
shortening, which in turns induces cellular senescence [7]. The Senes-
cence-Associated Secretory Phenotype (SASP) includes a number of
pro-inflammatory cytokines that sustain a pro-inflammatory micro-
environment, potentially contributing to inflammaging as shown in
vitro [4] and recently in vivo [8]. Other sources of inflammaging are not
mechanistically related to the passing of time. These include lifestyle,
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exposure to environmental factors and to infections [9,10]. The accu-
mulation of the individual response during lifespan (starting from fe-
cundation and possibly earlier in parental gametes) can shape the pro-
and anti-inflammatory phenotype of each individual, finally de-
termining the extent of inflammaging in adulthood and old age.
The intra- and extra-cellular environments experienced by each cell
during replications and quiescence, possibly contributing to in-
flammaging, can be recorded by an important molecular writer: epi-
genetic modifications. Epigenetics comprises the study of mitotically
(and sometimes meiotically) heritable alterations in gene expression
that do not imply changes in DNA sequence, but that rely on chemical
modifications of DNA and histone proteins. Epigenetic modifications
are essential mechanisms of developmental processes and are involved
in the establishment of tissue-specific cells’ identity. Such modifications
are stable across cell divisions, but also reversible, and hence guarantee
phenotypic plasticity and ability to respond relatively quickly to sti-
muli. Owing to their heritability, epigenetic changes are tied to cells’
memory, a metaphor to indicate the ability to somehow record events
that occurred in earlier cells’ generations.
It is therefore not surprising that epigenetic patterns undergo during
aging profound rearrangements [11–14] that have been associated with
the onset of age-related diseases [15]. The technological advances for
the analysis of epigenetic molecular markers achieved in the last two
decades showed that, in humans, all tissues, including immune cells
[16] undergo profound epigenetic changes during aging. However, our
understanding of how these changes are mechanistically related to
aging and age-related phenotypes – including inflammaging – is far to
be complete.
Epigenetics and inflammaging are two active research areas in aging
and the existence of a reciprocal relationship is almost given for
granted. Nevertheless, only a relatively limited number of studies has
specifically addressed this issue, investigating how age-associated epi-
genetic remodelling sustains inflammaging and, vice versa, how in-
flammaging can modulate epigenetic patterns. The aim of this review is
to recapitulate these evidences. We will briefly recall changes in DNA
methylation and histone modifications that occur during aging. Then,
we will review and discuss the available studies on the epigenetics of
inflammaging, focusing on those that describe age-dependent changes
in genes relevant for inflammaging and/or associations of the epige-
netic patterns with the levels of pro- and anti-inflammatory markers
[17,18]. Finally, the effect of environmental factors on the epigenetics
of inflammaging will be discussed.
2. Epigenetic modifications and their remodelling during aging
2.1. Epigenetic modifications
In this review we will focus on DNA methylation and histone
modifications. RNA-mediated transcriptional and post-transcriptional
gene silencing is often referred to as an epigenetic mechanism [19].
However, its role in inflammaging has been extensively reviewed
elsewhere [20,21] and therefore will not be discussed here.
DNA methylation consists in the covalent addition of a methyl
group to a cytosine, mainly within a CpG dinucleotide. In mammals,
CpG dinucleotides tend to be globally under-represented but enriched
in regions, known as CpG islands, typically located close to gene pro-
moters [22,23]. CpG sites out of CpG islands tend to be methylated,
while methylation of CpG islands is dynamically regulated during de-
velopment [24]. DNA methylation is catalysed by DNA methyl-
transferase enzymes (DNMTs), while demethylation can occur passively
during cell divisions or actively through the combination of oxidative/
deamination reactions and DNA repair mechanisms [25–27].
The most studied histone modifications include acetylation, me-
thylation and phosphorylation of histone tails [28]. Each type of
modification can occur at different residues of the histone tails and is
established and removed by specific classes of enzymes.
A complex and only partially characterized crosstalk governs the
relationship between DNA methylation and histone modifications [29].
The ultimate consequence of this interplay is the regulation of chro-
matin structure and the expression of the underlying DNA sequences.
Aging is characterized by a marked remodelling of epigenetic sig-
natures. Two types of changes have been widely characterized: 1)
general loss of heterochromatin and 2) reproducible gain or loss of
epigenetic markers at specific genomic locations. More recently, sto-
chastic epigenetic modifications (that is, not shared among individuals)
and increase in epigenetic variability have been described during aging
[30–32], but their relevance for inflammaging has not yet been ad-
dressed and as such will not be further discussed in this review.
2.2. Age-associated heterochromatin loss
Heterochromatin, a tightly packaged chromatin structure, ensures
transcriptional silencing and genomic stability at specific genomic do-
mains, including telomeres, centromeres, repetitive regions and trans-
posable elements [33]. Assembly and maintenance of heterochromatin
is governed by a complex crosstalk of epigenetic modifications, that
include trimethylation of lysine9 on histone H3 (H3K9me3) and DNA
methylation [34].
During cell senescence a profound reorganization of chromatin
structure occurs, characterized by loss of long-range chromosome in-
teractions and gain of short-range interactions [35–37]. These re-
arrangements lead to a global loss of constitutive heterochromatin, a
recognized hallmark of aging [38,39] occurring at the centromeric and
pericentromeric regions and in retrotransposons (Alu, SVA and LINE-1)
that show an increase in transcription rates and genomic copy number
[40,41]. These events, observed in several eukaryotic models of cell
senescence, are likely to contribute to genomic instability and to in-
crease mutation rates by retro-transposition [42,43]. Heterochromatin
loss is sustained by a decrease in histones synthesis and histones levels,
as observed in cellular models of replicative senescence and in human
fibroblasts from different age donors [44].
Furthermore, both histones post-translational modifications and
DNA methylation undergo profound changes during aging. H3K9me3
levels are reduced with aging and replicative senescence [45,46] and in
human models of age acceleration, including Hutchinson-Gilford pro-
geria syndrome [47,48] and Werner Syndrome [49]. Concomitantly,
global hypomethylation of DNA has been extensively observed in tis-
sues from aged individuals [50] and in cellular models of senescence
[51], fostered by age-associated changes in the expression and activity
of enzymes involved in epigenetic modifications contributing to het-
erochromatin loss. For instance, expression of the histone methyl-
transferase SUV39H1/2 is downregulated during aging [45,46], as is
the expression of DNMT1 [52].
At present it is not clear if heterochromatin loss is a side-effect of the
dysregulation of the epigenetic maintenance machinery during aging or
if it is - at least in part - the result of a regulated, programmed process.
Indeed, although usually referred to as “global”, age-associated loss of
heterochromatin is not a-specific and occurs preferentially at Alu re-
peats compared to LINE-1 sequences [50,53,54]. However, age-asso-
ciated decrease in LINE-1 methylation has also been reported [55,56].
2.3. Reproducible age-associated epigenetic changes
In addition to the prominent whole genome loss of heterochromatin
at repetitive sequences, several non-repetitive genomic regions, often
located in genes, gene promoters and surrounding sequences also un-
dergo epigenetic remodelling during aging. Depending on the genomic
region, these changes can consist in a gain or in a loss of specific epi-
genetic markers (for example, acquisition or loss of DNA methylation,
referred as hyper- or hypo- methylation, respectively) [11]. Epigenome-
wide association studies (EWAS) have provided a consistent repertoire
for the so called normative changes in epigenetic marks associated with
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aging, that is changes at specific genomic loci that reproducibly char-
acterize the epigenome of aged people. Most of these epigenetic mar-
kers of aging actually are DNA methylation markers, while our
knowledge of locus-specific histone changes during human aging is
scarcer [14,57,58]. This is mainly due to technical reasons, as pur-
ification of genomic DNA from whole blood and other human tissues is
much simpler compared to chromatin recovery and histones’ analysis.
Furthermore, EWAS studies on DNA methylation have enormously
benefited from the availability of Illumina Infinium microarrays, more
cost-effective than sequencing approaches, that have been used to
quantitatively measure methylation in thousands of subjects of different
ages. The chip assesses CpG sites (evolving from roughly 27,000 to
480,000 and up to 850,000 with the last version of the array) re-
presenting only a minor fraction of the 28 million CpG sites in the
human genome. However, the design of the microarray has proven to
be highly informative in reproducibly identifying hundreds of loci that
specifically undergo hypermethylation or hypomethylation with aging
[59–61].
The drivers of these site-specific age-associated DNA methylation
changes, as well as their functional and phenotypical consequences, are
largely unknown. Plausible hypotheses include that at least a fraction of
these changes is related to the accumulation of mitotic divisions
[62,63] or is the result of the purposeless continuation of develop-
mental programs [64]. On the other hand, it has also been hypothesised
that stochastic events, including molecular damage, converge in ste-
reotyped epigenetic changes at specific loci [14].
2.4. The epigenetic clocks
In the past years, normative changes in DNA methylation at specific
CpG sites have been combined in mathematical models able to estimate
chronological age [60,61,65–68]. The most popular among these
models are Horvath’s, based on 353 Infinium CpG probes [61] and
Hannum’s epigenetic clock, based on 71 Infinium CpG probes [60].
While Horvath’s clock can be applied to estimate epigenetic age in a
wide range of human tissues, Hannum’s clock is specific to whole blood.
The epigenetic age predicted according to these clocks is highly cor-
related with chronological age in physiological conditions, while de-
viations from this correlation can be informative of the presence of
biological signs of accelerated or decelerated aging. This is relevant as,
for example, epigenetic age acceleration – that is, an older biological
than chronological age– has been found in individuals affected by age-
related conditions such as Down Syndrome, Werner Syndrome, Par-
kinson’s and Alzheimer’s diseases, and it has been correlated with
morbidity and mortality (reviewed in Ref. [69]); on the other hand,
epigenetic age deceleration – that is, a younger biological than chron-
ological age– has been found in models of successful aging such as
centenarians and their offsprings [70,71]. Further refinements in Hor-
vath’s and Hannum’s predictions have been proposed to take into ac-
count variations in the cellular population composition (cell counts)
when measuring DNA methylation from whole blood [71]. As DNA
methylation patterns differ among blood cells types [72,73], changes in
their proportions can affect the estimation of epigenetic age of DNA
extracted from whole blood. The intrinsic epigenetic age acceleration
(IEAA) corrects Horvath’s prediction for blood cell counts to control this
bias. This means that, although calculated from whole blood, this es-
timation of epigenetic age is independent of blood cell types dynamics,
also affected by aging. On the contrary, the extrinsic epigenetic age
acceleration (EEAA) integrates Hannum’s estimation with known age-
related changes in blood cells composition and is thus informative of
immune system aging (immunosenescence). Accordingly, EEAA is cor-
related with markers of immunosenescence, while IEAA is not [74].
3. Age-associated epigenetic changes and inflammaging
In the following paragraphs we discuss some examples on how age-
associated epigenetic changes are related with and can functionally
contribute to inflammaging. It will be evident that current knowledge
in this field is still sparse and that a comprehensive view of the role of
epigenetics in the regulation of inflammaging remains an active area of
research.
3.1. Age-dependent heterochromatin loss and inflammaging
Evidences in the literature suggest that the quantitative loss of
heterochromatin during aging can contribute to inflammaging. Agrawal
et al. evaluated the activation of human monocyte-derived dendritic
cells, measured by the membrane expression of the co-stimulation
molecules CD80, CD86 and by the secretion of the cytokine IFN-α,
found to be upregulated, upon intracellular delivery of genomic DNA by
lipofectamine [75]. They showed that these markers of activation were
expressed more strongly when the delivered DNA was extracted from
blood of old (age 65–90 years) compared to young (age 20–35 years)
donors. Importantly, they experimentally demonstrated that the higher
immunogenicity of DNA from old donors was related to its hypo-
methylation compared to young donors. This experimental set-up po-
tentially mimics what happens in vivo when self DNA is released in
plasma and phagocytised by immune cells. Cell-free DNA (cfDNA) le-
vels increase during aging as a result of tissue necrosis, defective
clearance of apoptotic cells and inflammation itself [76–78]. It can be
speculated that age-associated hypomethylation and, more in general,
heterochromatin loss, increases the pro-inflammatory properties of
cfDNA. Indeed, unmethylated cfDNA resembles microbial DNA and it is
sensed by several types of intracellular receptors present in the cytosol
or in the endosomal membranes of various cell types, including den-
dritic cells [79]. For instance, among the many DNA immune sensors,
TLR9 -part of the Toll like receptor family expressed mainly in the
endosomal compartment- recognizes DNA motifs containing the dinu-
cleotide CG, mostly unmethylated in bacteria, and upon binding with
DNA, its activation results in the transcription of IFN-α and IFN-β as
well as other pro-inflammatory genes [80].
Other evidences in literature support a role for age-associated DNA
hypomethylation in increasing DNA immunogenicity. In nonagenarians
plasma levels of total and unmethylated cfDNA were associated with
the inflammaging markers IL-6 and CRP and with increased frailty [81].
Furthermore, Bellizzi et al. demonstrated that global hypomethylation
of buffy coat cells was associated with frailty in 65–85 years old in-
dividuals [82]. Alu demethylation is likely to contribute to these sig-
nificant associations, as in an independent study blood differential
LINE-1 methylation was not associated to CRP levels [83]. It is worth
noting that global genomic hypomethylation appeared to be delayed in
a cohort of offspring of long-lived parents (mean age 69.8+1.6 years)
[84]. Although these subjects did not differ specifically in the para-
meters related to inflammaging (CRP, IL-6) when compared to age-
matched individuals, they displayed a better health status compared to
controls [85].
It therefore follows that the epigenetic status of cfDNA can have an
effect on the global inflammaging profile, although several questions
remain unanswered. First, it is not clear to what extent cfDNA is able to
promote immune response in vivo during aging [86,87], a well-known
issue in elderly vaccination – treated in more details in the dedicated
review in this issue –, nor to what extent circulating DNAses, ensuring
rapid cfDNA clearance, are involved [88]. In addition, the origin of
cfDNA is not well characterized; it is plausible that different tissues
undergo age-associated heterochromatin loss to different extent and
upon different stimuli, thus differently contributing to the overall im-
munogenicity of cfDNA.
3.2. Gene-specific age-dependent epigenetic changes related to
inflammaging status
One of the most remarkable data linking age-dependent epigenetic
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remodelling and inflammaging is that the promoter of tumor necrosis
factor alfa (TNF-α) gene shows age-dependent DNA demethylation in
peripheral blood leucocytes and monocytes-derived macrophages [89].
Using a reporter gene construct, Gowers et al. demonstrated that the
methylation status of TNF-α promoter regulates its transcription, with
hypomethylation associated to upregulation of the gene. Remarkably,
this result was confirmed in an independent study [90] where DNA
methylation and gene expression were assessed in peripheral blood
mononuclear cells (PBMCs) from 5 young and 5 old donors.
The C-X-C motif chemokine 10 (CXCL10, also known as interferon
gamma-induced protein 10, IP-10), whose secretion is induced by in-
terferon gamma (IFN-γ) in monocytes, endothelial cells or fibroblasts, is
a chemoattractant and regulator of immune cell adhesion, for example
on endothelial cells. It was shown that methylation of CXCL10 has an
age-associated pattern similar to TNF-α gene [91]. In a cohort of 361
healthy young and old adults, DNA methylation of CXCL10 promoter
decreased with age in whole blood and was negatively associated with
plasma concentrations of the chemokine; a gene reporter construct
confirmed the inverse correlation between DNA methylation and ex-
pression of the gene. Interestingly, CXCL10 plasma levels were nega-
tively associated with working memory performance in the same co-
hort.
Age-specific epigenetic regulation has been demonstrated also for
IL-23. The behaviour of this major regulator of T-cell differentiation
towards the proinflammatory Th17 axis has been poorly investigated in
the frame of aging physiology [92] although it may seem paradoxical.
IL-23 induces the differentiation of naive CD4+T cells into pathogenic
helper T cells (Th17/ThIL-17) and its inactivation in animal models
leads to the suppression of the development of autoimmune diseases
[93,94]. In humans, production of IL-23 by whole blood cells upon TLR
stimulation was found to be decreased in frail elderly subjects [95]. On
the contrary, IL-23 levels are higher in plasma from 12- and 24-months-
old compared to young mice belonging to the senescence accelerated
mouse resistant 1 (SAMR1) strain [96], as well as in stimulated den-
dritic cells from old C57BL/6 mice compared to young ones [97]. In this
latter study, upon TLR ligation, dendritic cells from old mice showed an
increase in dimethylation of lysine 4 on histone H3 (H3K4me2) levels at
the promoter of the subunit p19 of IL23. This chromatin remodelling
was not observed in dendritic cells from young mice, indicating that
selective changes in H3K4 methylation occur with aging and contribute
to the increase in IL-23 protein production observed in aged mice.
The Krüppel-like factor 14 gene (KLF14), involved in adipose tissue
regulation, has a role in modulating macrophages inflammatory re-
sponse and in the pathogenesis of atherosclerosis [98]. Interestingly,
several independent reports described age-dependent hypermethylation
of the CpG island of KLF14 promoter in several tissues, including whole
blood, PBMC, liver and pancreatic islets [90,99–102], although no
correlation with gene expression in PBMC or islets was observed. Hy-
permethylation with aging was observed also in mouse spleen, adipose
tissue, kidney, lung, colon and whole blood [103], and in adipose tissue
its hypermethylation is associated with decreased KLF14 expression and
increased TNF-α and IL12 expression (Th1 pathway of T-cell differ-
entiation).
Decreased autophagy in macrophages with aging substantially
contributes to chronic inflammation [104]. Transcription of two au-
tophagy genes, ATG5 and LC3B, was found to be downregulated in
macrophages from aged versus young mice, and this reduced expression
is associated with DNA hypermethylation of the promoters of the two
genes [105].
At the current stage of knowledge, the genomic region whose DNA
methylation level is mostly associated with aging is the one mapping in
the promoter of ELOVL2 gene, encoding for an endoplasmic reticulum-
bound enzyme that catalyses the elongation reaction necessary to the
synthesis of the ω-3 fatty acid docosahexaenoic acid (DHA). DHA has
anti-inflammatory effects and is the precursor of pro-resolving lipid
mediators (resolvins, protectins and maresins). Progressive
hypermethylation of ELOVL2 occurs in almost all human tissues
[62,106] and has been observed also in mouse [107]. So far, ELOVL2
hypermethylation has not been associated to transcriptional down-
regulation of the gene and the functional consequences, if any, of this
normative epigenetic mark are not known. However, it is worth noting
that ELOVL2-deficient mice exhibit hyperactivation of M1 macrophages
and a pro-inflammatory phenotype in adipose tissues. Future studies
should evaluate if ELOVL2 hypermethylation with age can contribute to
inflammaging by impairing DHA-mediated anti-inflammatory pro-
cesses.
As not all organs or tissues age at the same rate, the tissue specificity
of age-associated epigenetic changes should be taken into account when
considering their contribution to inflammaging. A recent study de-
monstrated that age-associated DNA methylation changes are largely
tissue-specific [106]; however, the situations is highly multifaceted, as
some loci concordantly change in several (if not all) tissues [62], while
others show opposite behaviours (hyper- and hypo-methylation) in
different tissues [99]. Epigenetic changes that occur in cells of the
adaptive or innate immune system can directly modulate their pro- and
anti-inflammatory activity. At the same time, however, the epigenetic
remodelling of other tissues can also have an impact on inflammaging,
as it can affect the inflammatory phenotype of the microenvironment.
3.3. Epigenetic clocks and inflammaging
Despite the large number of studies that have used Horvath’s clock
to investigate age-related conditions, few have specifically considered
its association with inflammaging. A weak but statistically significant
positive correlation between EEAA and CRP levels (and, to a lesser
extent, between IEAA and CRP) was found in a cohort of 4490 in-
dividuals aged from 50 to 79 [108]. However, in the same study the
authors failed to validate this correlation in an independent, smaller
cohort of 407 subjects including males and females aged 30 years or
older. Irvin and colleagues provided a deeper analysis of the association
between IEAA/EEAA and inflammaging-related circulating markers in a
cohort including 830 subjects [109]. They confirmed the positive as-
sociation of EEAA with CRP and they showed positive associations of
EEAA with the level of circulating IL-6 and TNF-α that were dependent
on T cell type (naïve, regulatory, memory) percentages [110]. Asso-
ciation between EEAA and CRP levels was confirmed also in a small
cohort including 23 nursing home elderly aged 82–98 [111]. Taken
together, these results suggest that the association between age accel-
eration estimations and inflammaging is mediated by the age-associated
remodelling of the immune system compartments in blood [112], ra-
ther than being an intrinsic characteristic of the aging process.
4. Regulation of epigenetic patterns by inflammaging
As it often occurs in such complex interactions, it is to be expected
that chronic age-related inflammation also impinges on the remodelling
of epigenetic patterns, despite very limited work existing in this di-
rection.
In particular, if on one side heterochromatin loss can drive in-
flammaging, some evidences suggest that the reverse mechanism may
also operate, i.e. inflammaging can sharpen heterochromatin loss, thus
establishing a vicious circle. An in vitro model of inflammatory stress
show that treatment with IL-6 induces global hypomethylation of LINE-
1 repeats [113]. In addition, nuclear DNA damage, that can be triggered
by chronic inflammation [114], can induce global hypomethylation by
promoting a re-localization of DNMTs to damaged chromatin [115].
KDM6B, also known as JMJD3, is an inducible demethylase which
removes the repressive epigenetic marks H3K27me2 and H3K27me3
[116]. The expression of KDM6B is induced by various inflammatory
mediators, including IL-4 and TGF-β, via the NF-kB pathway [117], and
in turn the enzyme regulates inflammatory and immune responses.
KDM6B expression triggers cell senescence, possibly by controlling the
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nuclear localization of p53 [118,119] and by regulating the expression
of INK4 box genes [120]. Overexpression of KDM6B in glioma promotes
the expression of several cytokines associated with the SASP [121]. At
the same time, however, it has been reported in C. elegans that over-
expression of KDM6B increases lifespan [122].
Although these studies provide some mechanistic hints on how in-
flammatory mediators can modulate the activity of the epigenetic en-
zymes, future research will have to determine to which extent and with
which specificity the inflammaging milieu can modulate epigenetic
modifications.
5. Epigenetic signatures of inflammaging
A limited number of studies exists on the direct relation between
epigenetic signatures and inflammation, and it is indeed among the
aims of this review to recollect and harmonize existing work in this
view. Rather than considering the association between age-associated
epigenetic changes and inflammaging, whose data are currently
missing, these studies have specifically evaluated the association be-
tween DNA methylation and pro- and anti-inflammatory cytokines in
cohorts of elderly subjects.
One of the first studies of this kind evaluated the association be-
tween circulating CRP and genome-wide blood DNA methylation in a
cohort of 966 African American participants (mean age: 66 years old)
enriched for hypertensive subjects [123]. They identified 257 differ-
entially methylated CpG sites mapping in 240 genes enriched for im-
mune response and inflammatory functions. In the study from Neva-
lainen et al. the authors evaluated the association between circulating
IL-6 and transcriptomic/epigenomic profiles in PBMC from 156 non-
agenarians [124]: significant associations were found in men but not in
women and further mapped on genes involved in inflammatory re-
sponses, such as IL1RN, CREB5 and FAIM3.
In a subsequent study, whole blood genome-wide DNA methylation
and gene expression were associated with CRP levels in adult in-
dividuals of European (8863 participants) and African-American (4111
participants) ancestry [125]. Fifty-eight CpG sites were found to be
reproducibly associated with CRP in both cohorts, explaining 6% of the
variation in CRP plasma levels, and 4 of them mapped on genes whose
expression correlates both with DNA methylation and CRP levels.
Pathway enrichment analysis on this methylation signature of in-
flammaging included IL-6 and IL-9 signalling and several of the iden-
tified CpG sites mapped on genes involved in the regulation of in-
flammation, such as AIM2 and SOCS3. AIM2 encodes for an IFN-γ
inducible protein that recognizes altered or mislocalized DNA and in-
itiates the assembly of the inflammasome by promoting caspase-1 ac-
tivation and pro-IL1 pro-IL18 cleavage [126]. Methylation of AIM2 was
negatively associated with the expression of the gene and with CRP
levels; interestingly, we found that in publicly available datasets AIM2
methylation decreases with aging (data not shown) in agreement with
age-associated increase in CRP levels. Finally, SOCS3 is induced by
various cytokines, including IL-6, IL-10, and IFN-γ and it encodes for a
negative regulator of STAT3 signalling. SOCS3 methylation was nega-
tively associated with CRP levels in an independent study [127] where
whole blood and adipose tissue DNA methylation was evaluated. Im-
portantly, of the 58 CpG sites identified by Ligthart et al., 25 were
demonstrated to be associated with circulating levels of TNF, IL-6, IL-8
or IL-10 in an independent study performed on a small cohort including
14 community-dwelling adults from 48 to 78 years old [128].
The efficacy and conceptual appeal of epigenetic clocks has
prompted the search for predictors to better characterize life- and
health-span. As a result, recent efforts have produced a new clock,
termed DNAm PhenoAge [129]. The model was built to include CpGs
whose methylation is associated with a set of 10 parameters in-
formative of phenotypic age (chronological age, albumin, creatinine,
glucose, lymphocyte percent, mean cell volume, red cell distribution
width, alkaline phosphatase, white blood cell counts and CRP). The
inclusion of CRP among the selected parameters is noteworthy, along
with the presence of a CpG site mapping on AIM2 in the list of 513
probes included in the model. DNAm PhenoAge was shown to outper-
form the previous version of the clocks in terms of prediction for all-
cause mortality and aging-related morbidity and to positively correlate
with the transcription of genes involved in several pro-inflammatory
signalling pathways.
6. Modulation of the epigenetics of inflammaging by
environmental stimuli
In the past years a wealth of studies has provided robust evidence
that environments that have been experienced not only during adult-
hood, but also in utero, infancy and childhood shape the immune
phenotype and contribute to explain its functional variations during
aging [2,130,131]. Epigenetic remodelling has often been brought into
play to explain the effect of early events on the development of cardi-
ovascular, metabolic, neurodegenerative and psychiatric diseases in
adulthood [132–134]. Dietary components, environmental agents,
stressful exposures and drugs have been shown to affect gene-specific
and whole genome methylation [135,136] and some of them are cur-
rently under investigation to assess their ability to reverse disease-as-
sociated epigenetic profiles [137–141]. Despite this large amount of
evidences, little is known about how these epigenetic modifiers com-
bine and interact during the life course, and even less is known on their
effect of the epigenetic patterns that sustain or dampen the in-
flammatory phenotype in the elders. In the following paragraphs, we
will specifically discuss current knowledge on the role of environmental
agents in mediating the interaction between epigenetics and in-
flammaging. As it will be evident, most of these studies are descriptive
and mechanistic insights are still missing. As a consequence, it is hard to
conclude whether the observed epigenetic changes are cause or con-
sequence of the chronic inflammatory phenotype. What seems more
likely is that a reciprocal interaction between the levels of pro- and anti-
inflammatory cytokines and epigenetic marks exists.
6.1. Nutritional compounds
Nutritional habits can affect inflammaging and dietary interventions
are promising strategies to modulate it and treat age-related diseases
[1,5,137,142–145].
Caloric restriction and caloric restriction mimetics (for example,
resveratrol and quercetin) have anti-inflammatory properties
[144,146]. They act by orchestrating a complex network of molecular
pathways [147] that include the activation of the histone deacetylase
Sirtuin 1 (SIRT1). SIRT1-dependent deacetylation of histones and
transcription factors (NF-κb, AP-1) negatively regulates the expression
of inflammation-related genes [96,148–150]. SIRT1 expression de-
creases with aging [151] and it is conceivable that interventions
prompting its activation could counteract age-associated chronic in-
flammation.
Mediterranean diet (MedDiet), universally known for its beneficial
anti-inflammatory effects, is particularly enriched in compounds able to
modify the activity of epigenetic enzymes [137]. In the “Prevención con
Dieta Mediterránea” (PREDIMED) study the effect of MedDiet on
genome-wide DNA methylation was evaluated in a cohort of 36 subjects
(age range: 55–80 years) at high risk to develop cardiovascular disease
[152]. The eight genes (EEF2, COL18A1, IL4I1, LEPR, PLAGL1, IFRD1,
MAPKAPK2, PPARGC1B) identified as differentially methylated with
respect to baseline are all involved in the regulation of inflammation.
Notably, in the same study methylation of EEF2, which controls TNF-α
translation [153], correlates with plasma levels of TNF-α and CRP,
whose concentrations decrease after MedDiet intervention.
Among the nutritional compounds, zinc has attracted particular
attention owing to its anti-oxidant and anti-inflammatory properties
[154] and zinc deficiency being associated with higher susceptibility to
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infections and systemic inflammation [155,156]. Plasma zinc con-
centrations decline with age [157–159] possibly due to lower zinc
dietary intake in the elderly, also as a consequence of age-related al-
terations in sensitivity for salty taste [160]. Evidences from mouse
models suggest that age-associated zinc deficiency can also have epi-
genetic basis. Thymocytes, splenocytes and bone marrow cells from
aged mice displayed intracellular decrease in zinc concentration with
respect to young animals and concomitantly show hypermethylation of
the CpG island at the promoter of SLC39A6 gene, encoding for a zinc
transporter [161]. This did not affect baseline expression of the gene,
which on the contrary was upregulated in splenocytes after lipopoly-
saccharide (LPS) stimulation in young but not in old mice. Not only zinc
deficiency can be epigenetically mediated during aging, but it can also
exert its pro-inflammatory action by epigenetic mechanisms [162,163].
Indeed, zinc deficiency was associated with hypomethylation and
overexpression of IL6 in cell culture models and in cells from aged mice
and humans [163]. At present, however, it is not clear if and to what
extent dietary zinc supplementation could improve the inflammatory
landscape of the elderly [164].
6.2. Pollutants
Exposure to environmental pollutants can contribute to aging and
age-related diseases by sustaining a chronic pro-inflammatory status
[165]. Accordingly, air pollutants (particulate matter, black carbon,
ozone) and persistent organic pollutants (organic compounds deriving
from inappropriate disposal of chemical and electronic products) have
been associated to increase in pro-inflammatory cytokines in multiple
independent studies [166–168]. DNA methylation changes in genes
relevant to inflammaging have been reported in humans and animal
models exposed to environmental pollutants. For example, in the Nor-
mative Aging Study, exposure to black carbon and particulate matter
was associated with changes in methylation of IL-6 and IFN-γ [169] and
hypomethylation of LINE-1 in blood cells [170]. The latter was ob-
served also in a cohort including adults living near an electronic waste
area, together with an increase in plasma levels of IL-6 and IL-10 with
respect to controls [168]. If on one side these studies suggest an im-
portant role of epigenetics in mediating the pro-inflammatory effects of
environmental pollutants, on the other side it is still not clear if and
how long these changes can persist after acute exposures [171,172]
and, more in general, how the extent, the frequency and the duration of
exposures can ultimately impinge on epigenetic patterns and contribute
to chronic inflammation in the elderly.
6.3. Socioeconomic environment
Lower socioeconomic status (SES) is associated with increased
chronic inflammation [173,174], earlier onset of age-related disease
and increased mortality [175]. The fact that individuals with lower SES
have unhealthy lifestyle habits and higher rate of risk factors for
chronic diseases explain only in part these associations, suggesting that
psychosocial stressors and socioeconomic adversity can directly im-
pinge on the regulation of chronic inflammation. Early life seems to be
a sensitive window in which the experienced SES is particularly im-
portant in determining the inflammatory phenotype in adulthood
[176].
Some recent reports suggest that epigenetic modifications can
mediate the impact of SES on inflammaging. In the pSoBid cohort, re-
cruited in the NHS Greater Glasgow Health Board area and including
subjects from 35 to 64 years of age, the total content of methyl groups
in blood cells (global DNA methylation) was decreased in most socio-
economically deprived group of participants, independently from the
diet, and inversely correlated with IL-6 levels [177]. A study performed
in macaques showed that dominance rank, a proxy for social status, was
associated with PBMC altered methylation in inflammatory genes
(NFATC1, which regulates the expression of cytokines in T cell ; CXCR2,
which encodes for a IL-8 receptor; and PTGS2, which encodes for a key
enzyme in prostaglandin biosynthesis) [178]. These observations were
confirmed and expanded in blood from a cohort of 857 adult partici-
pants from the EPIC study, where different indicators of SES were taken
into account [179]. In monocytes from more than 1200 participants
from the Multi-Ethnic Study of Atherosclerosis (MESA; mean age: 70
years), low childhood SES, low adulthood SES social mobility and living
in disadvantaged neighborhood were associated with altered methyla-
tion of several inflammation-related genes (including CCL1, CD1D, F8,
KLRG1, NLRP12), and expression of a subset of these genes was asso-
ciated to methylation levels [180,181].
6.4. Microbial exposures
Interesting insights in this field come from the work of the biological
anthropologist Thomas McDade, who adopted an ecological framework
to study chronic low-grade inflammation in adulthood. McDade showed
that adults from low-income countries, such as Philippines or Ecuador,
have lower circulating levels of CRP with respect to age-matched sub-
jects from industrialized countries like the United States [10]. This
phenotype was not explained by differences in genetic background or
adulthood BMI, but was ascribed to the marked differences in nutri-
tional and microbial exposures experienced early in life and in infancy.
According to this view, the higher burden of infectious diseases in low-
and middle-income countries actively engages the immune system
during critical stages of its development, resulting in the ability to ef-
fectively turn on or off the inflammation as appropriate in adulthood
and, possibly, in old age. On the contrary, the immune system of in-
dividuals born in more sanitate environments is less trained and more
prone to a pro-inflammatory phenotype. Interestingly, McDade and
colleagues found that in a cohort of 494 young adults (age 20–22 years)
DNA methylation of genes involved in inflammatory processes (CD8A,
APBA2, IL1A and PIK3C2B) was associated with exposure to animal
feces and season of birth, two proxies of the intensity and diversity of
microbial exposures in early life [182]. Some of the identified CpG sites
correlated with the values of an inflammation index built up from the
plasma levels of CRP, IL-6, TNFα, IL-10, IFNγ, IL-1β and IL-8. Although
these results are of potential interest for the study of the epigenetics of
inflammaging, it is difficult to extrapolate what happens in the elderly,
given the young age of the participants.
Further contribution to disentangle the complexity of the role of
infections in the crosstalk between epigenetics and inflammaging may
come by a phenomenon that has been recently framed under the name
of trained immunity [183]. The term has been relatively recently coined
[184] to distinguish this mechanism from what is usually intended by
“memory” in the adaptive immune system (i.e. trained versus adaptive
immunity) and describes previously overlooked means by which the
host innate immune system copes with infections.
Infection encompasses a wide range of situations where blood cir-
culating monocytes are often recruited in tissues to differentiate in re-
sident macrophages. By doing so, macrophages are key contributors for
the control of bacteria or fungi but also for orchestrating repair me-
chanisms. In recent years, it has been uncovered that pathways of dif-
ferentiation may be diverse based on the genetic programs they unfold,
accompanied by very diverse consequences. For example, in severe
sepsis macrophages undergo long term functional palsy making them
tolerant to further infection insults. Conversely, in the course of a
productive response, they reach a state of permanent modifications that
make them more prone to react to a second challenge with the same
microbial stimulus by an increased production of pro-inflammatory
cytokines [185]. This long-term activated (trained) phenotype relies on
epigenetic changes in monocytes chromatin, consisting in an increase in
mono- and trimethylation of histone H3 at lysine 4 that has been as-
sociated with an up-regulation of the expression of pro-inflammatory
cytokines [186].
It is likely that many types of trained immunity do exist depending
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on context and inducers. Interestingly, trained immunity can also be
severely down-modulated after encounter with fungi which may re-
present a protection mechanism against septic shock, extending the
complexity and entanglement among diverse types of infections and
their outcome [187].
In aging, where the innate compartment of the immune system is
hyperfunctional, leading to the state of inflammaging, the question
would be to know if the past history of immune reactions of an in-
dividual can imprint to the immune system, and more specifically to its
innate compartment, a behavior bias susceptible to explain the wide
range of aging phenotypes found to exist among individuals as well as
their association with co-morbidities [2,188]. Trained circulating
monocytes are present several months after stimulation, but studies at
longer time points are still missing. Recently, the concept of trained
immunity has been found to be also applicable to myeloid precursor
cells in the bone marrow [189,190]. Although the role of epigenetic
changes has not been yet addressed in this setting, these observations
extend the potential consequences on inflammaging of microbial ex-
posure, vaccination or other environmental factors like diet. For ex-
ample, a Western-type diet for 4 weeks followed by a chow diet for 4
weeks induced profound transcriptional and epigenetic changes in cir-
culating monocytes and bone marrow progenitors in the athero-
sclerosis-prone Ldlr−/− mice [191]. These partial answers seem to
indicate that trained immunity can contribute to inflammaging and age-
relate diseases, but further studies are required in this sense.
7. Conclusions
We presented a focused review of the available experimental evi-
dences linking inflammaging with epigenetic mechanisms and in par-
ticular with age related epigenetic remodelling. Altogether such evi-
dences support the idea that these phenomena can be causally linked.
Some clues indicate that inflammaging and epigenetic remodelling can
sustain each other, likely feeding vicious circles and representing a
significant contributor to age-related physiological decline and dis-
eases. However, our knowledge in this field is still limited and further
research is needed that explore this topic, in particular to overcome a
number of the study designs’ shortcomings.
In particular, most of the studies that have analysed the association
between inflammaging markers and epigenetic changes were per-
formed in whole blood. Although whole blood is one of the most ac-
cessible sources of biospecimens in human, it is difficult to infer me-
chanistic insights from these measurement, given the high variability in
blood cell types that can differently contribute to the epigenetic signal
and to the inflammaging phenotype. The epigenetic characterization of
selected populations of cells is thus needed, together with mechanistic
studies in cellular and animal models. Furthermore, the relationship
between systemic and local inflammaging [192,193] should be ad-
dressed also from an epigenetic point of view. Recent results from our
group demonstrated that fibroblasts from centenarians, a well estab-
lished model of healthy aging, show reduced production of IL-6 com-
pared to cells from old-age donors, possibly due to hypomethylation of
the RNAseH2C gene which degrades RNA:DNA hybrids (Storci et al.,
submitted). Conversely, the same gene was hypermethylated in ather-
osclerotic plaques and cancer tissues. Thus, future studies will have to
consider the contribution to inflammaging of epigenetic changes in
non-circulating cells, including resident macrophages.
Another issue is related to the effects on inflammaging of (early)
environmental exposures. Although this topic needs long lasting long-
itudinal studies, the combination of results from animal models with
the targeted analysis of existing and newly generated data will provide
insights on how the turn of the events experienced during the life course
ultimately results in a lower of higher grade of chronic inflammation in
the elderly.
In conclusion, there is the urgent need to further elucidate the
connection between epigenetic remodelling and inflammaging. Besides
shedding light on the molecular basis of chronic inflammation in the
elderly, these studies will result in a new category of markers of in-
flammaging. Indeed, epigenetic modifications have proven to be extra
ordinary sources of robust and reproducible biomarkers of aging and
age-related phenotypic traits, more stable than RNA or protein based
biomarkers. Lastly, the current thrive of epigenetic drugs and inter-
ventions will soon provide new strategy to combat inflammaging.
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